RankingsPricing
  1. US-listed companies
  2. Citius Pharmaceuticals, Inc.
  3. Raw

Citius Pharmaceuticals, Inc.CTXR

Market cap
$10.7M
P/E ratio
SummaryFinancials
Back to summarized table
Sep 30,
2011		Sep 30,
2012		Sep 30,
2013		Sep 30,
2015		Sep 30,
2016		Sep 30,
2018		Sep 30,
2019		Sep 30,
2020		Sep 30,
2021		Sep 30,
2022		Sep 30,
2023		Sep 30,
2024
Cash and cash equivalents212135-676,137294,35198147042263
Inventory-----------8
Prepaid expenses---60,000598,48457,73248,111122,2373383
Total Current Assets212135-736,137892,8351081473453414
Property and equipment, net----3,7421,4835901,5777,0234,1001,432-
Operating lease right-of-use asset, net-------986,204822,828646,074454,426246,247
Deposits-----------38,062
In-process research and development-----19191959595993
Goodwill----22299999
Total Other Assets-----------102
Total Assets212135-741,53822312944142114104117
Accounts payable906-11,474559,150909,1562321135
License payable-----------28
Accrued expenses3,9504,150-8,260958,101181,657246,225164,040621,9601476,30017,027
Accrued compensation----903,2501122222
Operating lease liability-------158,999177,237196,989218,380241,547
Total Current Liabilities24,05345,98214,6941535445636
Deferred tax liability-------55667
Operating lease liability – non current-------855,471678,234481,245262,86521,318
Total Liabilities-------1010111243
Preferred stock - $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding------------
Common stock - $0.001 par value; 16,000,000 shares authorized; 7,247,243 and 6,354,371 shares issued and outstanding at September 30, 2024 and 2023, respectively18,00018,00018,00034,11873,13816,19928,93055,577145,979146,211158,8587,247
Additional paid-in capital--62,5228346880104228232253271
Accumulated deficit----9,040,549-17,336,247-40,257,838-55,819,982-70,593,867-96,047,821-129,688,467-162,231,379-201,370,218
Total Citius Pharmaceuticals, Inc. Stockholders’ Equity-23,841-45,847-14,694-635,213172824341331039174
Non-controlling interest--------600,380600,380600,3804
Total Equity--------1331039174
Total Liabilities and Equity212135-741,53822312944142114104117